Evidence map›Paper›PMID 33859294›Full record

ArticleScientific reports2021

High-throughput enrichment and isolation of megakaryocyte progenitor cells from the mouse bone marrow.

Lucas M Bush, Connor P Healy, James E Marvin, Tara L Deans

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Advancing in vivo reprogramming with synthetic biology.Current opinion in biotechnology · 2024
    Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lucas M BushDepartment of Biomedical Engineering, University of Utah, Salt Lake City, UT, 84112, USA.
Connor P HealyDepartment of Biomedical Engineering, University of Utah, Salt Lake City, UT, 84112, USA.
James E MarvinFlow Cytometry Core Facility, University of Utah Health Sciences Center, Salt Lake City, UT, 84112, USA.
Tara L DeansDepartment of Biomedical Engineering, University of Utah, Salt Lake City, UT, 84112, USA. tara.deans@utah.edu.
University of Utah · US

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI KATHARINE S ULLMAN · 1986 to 2026
$72.6M
RESEARCH TRAINING IN HEMATOLOGYT32DK007115 · NIDDK · UNIVERSITY OF UTAH · PI LEIBOLD, ELIZABETH ANN, PRCHAL, JOSEF T · 1986 to 2020
$8.4M
Engineered platelets for the targeted destruction of circulating tumor cells - Administrative SupplementDP2CA250006 · NCI · UNIVERSITY OF UTAH · PI DEANS, TARA LYNN · 2019 to 2022
$2.4M
Engineering novel delivery systems with synthetic biologyR21EB025413 · NIBIB · UNIVERSITY OF UTAH · PI DEANS, TARA LYNN · 2018 to 2020
$609k
Amnis ImageStreamX MarkII Imaging Flow CytometerS10OD026959 · OD · UNIVERSITY OF UTAH · PI MARVIN, JAMES E · 2020 to 2020
$517k
Univ of Utah Cell Sorter for Flow Cytometry CoreS10RR026802 · NCRR · UNIVERSITY OF UTAH · PI GREEN, WAYNE FRANCIS · 2010 to 2010
$500k
NCI NIH HHS DP2 CA250006NCI NIH HHS P30 CA042014NCRR NIH HHS S10 RR026802NIBIB NIH HHS R21 EB025413NIDDK NIH HHS T32 DK007115NIH HHS S10 OD026959
6 · The paper itself

Abstract

Megakaryocytes are a rare population of cells that develop in the bone marrow and function to produce platelets that circulate throughout the body and form clots to stop or prevent bleeding. A major challenge in studying megakaryocyte development, and the diseases that arise from their dysfunction, is the identification, classification, and enrichment of megakaryocyte progenitor cells that are produced during hematopoiesis. Here, we present a high throughput strategy for identifying and isolating megakaryocytes and their progenitor cells from a heterogeneous population of bone marrow samples. Specifically, we couple thrombopoietin (TPO) induction, image flow cytometry, and principal component analysis (PCA) to identify and enrich for megakaryocyte progenitor cells that are capable of self-renewal and directly differentiating into mature megakaryocytes. This enrichment strategy distinguishes megakaryocyte progenitors from other lineage-committed cells in a high throughput manner. Furthermore, by using image flow cytometry with PCA, we have identified a combination of markers and characteristics that can be used to isolate megakaryocyte progenitor cells using standard flow cytometry methods. Altogether, these techniques enable the high throughput enrichment and isolation of cells in the megakaryocyte lineage and have the potential to enable rapid disease identification and diagnoses ahead of severe disease progression.

Indexed as

Bone Marrow CellsMegakaryocytesStem CellsAnimalsBlood PlateletsCell DifferentiationCell Self RenewalCell SeparationFlow CytometryHematopoiesisMiceThrombopoietinThrombopoietin

Identifiers

PMID33859294
PMCPMC8050096
OpenAlexW3155662899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.